October 23, 2026 · O&G open · DOI: 10.1097/og9.0000000000000214

Long-Acting Injectable Buprenorphine in Pregnancy.

Listen to this summary

This retrospective chart review of 12 pregnant individuals at one academic medical center asked how long-acting injectable buprenorphine (mostly monthly formulations) is used in practice, particularly among those initiating it during pregnancy after nonprescribed fentanyl use. Ten of the 12 started the medication during pregnancy via low-dose buprenorphine initiation, and retention on any opioid use disorder medication at delivery was high (91.7%), though 66.7% remained on the injectable itself and four patients switched to methadone. The authors conclude that LAI buprenorphine can be used successfully in this population with supplemental sublingual buprenorphine commonly prescribed, and that individualized care is important given the small sample size.

Erin C Nacev, Kristin C Prewitt, Linda Peng, Eugene Song, Honora Englander, Patricia Liu

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play